Stocks
Moderna (MRNA) EBITDA margin US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -278.0% | 75.0% | 51.5% | 50.7% | -47.5% | -79.5% | ||
| Changes by years, y/y, % | +858pp | +353pp | -23pp | -1pp | -98pp | -32.4% | |||
Moderna. EBITDA margin, %
Moderna. EBITDA margin, changes, pp
Moderna (MRNA) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
| EBITDA margin, % | ? | -109.9% | -96.3% | 10.7% | -736.5% | -548.5% | -79.5% | |
| Changes by years, y/y, % | -152pp | -138pp | -20pp | -721pp | -33pp | |||
| Changes by quarters, q/q, % | +406pp | +14pp | +107pp | -747pp | +188pp | |||
